ERBB2 and breast carcinoma: In our study, breast cancer was associated with very similar long-term survival rates across most age cohorts, which may also be attributed to the higher incidence of certain more aggressive subtypes of BC in younger ages, such as triple-negative BC and HER2+ BC, which are associated with a worse prognosis [64,65].